CD274 and neoplasm: Ex vivo evaluation of the DC phenotypic and functional characteristics, and of the T-cell functions following tumor antigen recognition on DCs, showed that PD-L1-silenced DCs presented a potent immunotherapeutic approach in combination with PD-1 siRNA loaded NPs.